Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Breast Diseases × Goserelin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Breast Neoplasms 2 Stage I Prostate Adenocarcinoma AJCC v7 1 Neoplasms 1 Castration-resistant Prostate Cancer Patients with Oligometastases 1 Breast Diseases 1

Interventions

Tamoxifen 1 Letrozole 1 Lapatinib 1 Goserelin 1 Epirubicin 1 Doxorubicin 1 Docetaxel 1 Cyclophosphamide 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03373708 2017-12-18

Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer

Shandong Cancer Hospital and Institute

Phase 2/3 Unknown

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡